Christopher John Kenney - Net Worth and Insider Trading
Christopher John Kenney Net Worth
The estimated net worth of Christopher John Kenney is at least $0 dollars as of 2024-12-01. Christopher John Kenney is the Chief Medical Officer of Xenon Pharmaceuticals Inc and owns about 0 shares of Xenon Pharmaceuticals Inc (XENE) stock worth over $0. Details can be seen in Christopher John Kenney's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Christopher John Kenney has not made any transactions after 2023-03-24 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Christopher John Kenney
Christopher John Kenney Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Christopher John Kenney owns 1 companies in total, including Xenon Pharmaceuticals Inc (XENE) .
Click here to see the complete history of Christopher John Kenney’s form 4 insider trades.
Insider Ownership Summary of Christopher John Kenney
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| XENE | Xenon Pharmaceuticals Inc | 2023-03-24 | Chief Medical Officer |
Christopher John Kenney Latest Holdings Summary
Christopher John Kenney currently owns a total of 1 stock. Christopher John Kenney owns 0 shares of Xenon Pharmaceuticals Inc (XENE) as of March 24, 2023, with a value of $0.
Latest Holdings of Christopher John Kenney
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| XENE | Xenon Pharmaceuticals Inc | 2023-03-24 | 0 | 42.63 | 0 |
Holding Weightings of Christopher John Kenney
Christopher John Kenney Form 4 Trading Tracker
According to the SEC Form 4 filings, Christopher John Kenney has made a total of 2 transactions in Xenon Pharmaceuticals Inc (XENE) over the past 5 years, including 1 buys and 1 sells. The most-recent trade in Xenon Pharmaceuticals Inc is the sale of 700 shares on March 24, 2023, which brought Christopher John Kenney around $24,507.
Insider Trading History of Christopher John Kenney
- 1
Christopher John Kenney Trading Performance
GuruFocus tracks the stock performance after each of Christopher John Kenney's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Christopher John Kenney is 25.85%. GuruFocus also compares Christopher John Kenney's trading performance to market benchmark return within the same time period. The performance of stocks bought by Christopher John Kenney within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Christopher John Kenney's insider trading performs compared to the benchmark.
Performance of Christopher John Kenney
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 20.46 | | | | | |
| Relative Return to S&P 500(%) | 21.58 | | | | | |
Christopher John Kenney Ownership Network
Christopher John Kenney Owned Company Details
What does Xenon Pharmaceuticals Inc do?
Who are the key executives at Xenon Pharmaceuticals Inc?
Christopher John Kenney is the Chief Medical Officer of Xenon Pharmaceuticals Inc. Other key executives at Xenon Pharmaceuticals Inc include SVP Bus. & Corp. Development Sherrington Robin , director & PRESIDENT & CEO Ian Mortimer , and Chief Legal Officer Andrea Difabio .
Xenon Pharmaceuticals Inc (XENE) Insider Trades Summary
Over the past 18 months, Christopher John Kenney made no insider transaction in Xenon Pharmaceuticals Inc (XENE). Other recent insider transactions involving Xenon Pharmaceuticals Inc (XENE) include a net sale of 31,467 shares made by Gary Patou , a net sale of 25,000 shares made by Dawn Svoronos , and a net sale of 13,000 shares made by Steven Gannon .
In summary, during the past 3 months, insiders sold 4,891 shares of Xenon Pharmaceuticals Inc (XENE) in total and bought 0 shares, with a net sale of 4,891 shares. During the past 18 months, 78,696 shares of Xenon Pharmaceuticals Inc (XENE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 78,696 shares.
Xenon Pharmaceuticals Inc (XENE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Xenon Pharmaceuticals Inc Insider Transactions
Christopher John Kenney Mailing Address
Above is the net worth, insider trading, and ownership report for Christopher John Kenney. You might contact Christopher John Kenney via mailing address: 200 - 3650 Gilmore Way, Burnaby, A1 V5g 48w.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
